Table 1.
Kinase inhibitors |
||||
---|---|---|---|---|
Treatment | Total Cx43 expression | w/PKI (PKA inhibition) | w/DT-2 (PKG inhibition) | w/CalC (PKC inhibition) |
8Br-cAMP | ↑ | ↓ | ↓ | ↓ |
8Br-cGMP | ↑ | – | ↓ | ↓ |
BAY 41-2272 | ↑ | – | ↓ | ↓ |
DADS | ↑ | – | – | – |
Kinase inhibitors |
||||
---|---|---|---|---|
Treatment | Total Cx43 expression | w/PKI (PKA inhibition) | w/DT-2 (PKG inhibition) | w/CalC (PKC inhibition) |
8Br-cAMP | ↑ | ↓ | ↓ | ↓ |
8Br-cGMP | ↑ | – | ↓ | ↓ |
BAY 41-2272 | ↑ | – | ↓ | ↓ |
DADS | ↑ | – | – | – |